Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: A case-control study Academic Article Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Antineoplastic Combined Chemotherapy Protocols
  • Genital Neoplasms, Female

abstract

  • Tubal ligation is a feasible option to reduce the risk of ovarian cancer in women with BRCA1 mutations who have completed childbearing.

publication date

  • May 12, 2001

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0140-6736(00)04642-0

PubMed ID

  • 11377596

Additional Document Info

start page

  • 1467

end page

  • 70

volume

  • 357

number

  • 9267